A swiss life science company, spin off of UZH developing personalized skin tissue therapy to treat skin defects and beyond.
Grabenstrasse 11, 8952 Schlieren, Switzerland
Cell Receptor Inc. has IP for improving results in oncological treatment by targeting upstream steps of growth signaling, not noticed in oncology yet. A well-tolerated affordable treatment of low toxicity! It will prevent metastasis in most cancers.www.nature.com/articles/d43747-021-00133-8
MD Bioproducts is a manufacturer and provider of antibodies, reagents and custom assays for inflammatory and autoimmune diseases, neurology, metabolism, immunology, endocrinology, and oncology research. With 30 years of experience, MD Bioproducts offers pharmaceutical, biotech, academic and government communities tools to enable researchers to reach their objectives faster and more reliably.
Quality Products that Contribute to Your Research Success: Antibodies, Disease Induction Reagents for in vivo / in vitro, ELISAs, Collagen, Isotype Controls, Peptides, Antigens, Proteins, Cell Culture Reagents, ArthritoMab®, MonELISA®.